Understanding how lung cells regenerate after injury
Control of lung alveolar regeneration by Dot1L/H3K79 methylation
This study is looking at how certain lung cells can help heal damaged lungs, which could lead to better treatments for people with lung injuries or chronic lung diseases.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Pennsylvania NIH-funded |
| Lab location | 1 site (Philadelphia, United States) |
| Project ID | NIH-11018540 on NIH RePORTER |
What this research studies
This research investigates the mechanisms behind the regeneration of lung alveoli, which are essential for breathing and responding to environmental threats. It focuses on a specific type of lung cell, the alveolar type 2 (AT2) cell, which can transform into another type of cell to help repair damaged lung tissue. By using advanced techniques, including small molecule screening and organoid assays, the study aims to identify pathways that enhance the repair process in the lungs. This could lead to new treatments for patients suffering from acute lung injuries or chronic lung diseases.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals who have experienced acute lung injuries or have chronic lung conditions affecting their alveoli.
Not a fit: Patients with stable lung conditions that do not involve acute injury or significant regeneration needs may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to innovative therapies that improve lung healing and function in patients with acute lung injuries.
How similar studies have performed: Previous research has shown promise in understanding lung cell regeneration, but this specific approach focusing on Dot1L and H3K79 methylation is relatively novel.
Where this research is happening
Philadelphia, United States
- University of Pennsylvania — Philadelphia, United States (Active)
Researchers
- Principal investigator: Morrisey, Edward E — University of Pennsylvania
- Study coordinator: Morrisey, Edward E
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.